(NASDAQ: ASPI) Asp Isotopes's forecast annual revenue growth rate of 269.71% is forecast to beat the US Chemicals industry's average forecast revenue growth rate of 12.52%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.16%.
Asp Isotopes's revenue in 2024 is $433,026.On average, 1 Wall Street analysts forecast ASPI's revenue for 2024 to be $572,402,329, with the lowest ASPI revenue forecast at $572,402,329, and the highest ASPI revenue forecast at $572,402,329. On average, 1 Wall Street analysts forecast ASPI's revenue for 2025 to be $768,095,433, with the lowest ASPI revenue forecast at $768,095,433, and the highest ASPI revenue forecast at $768,095,433.
In 2026, ASPI is forecast to generate $1,091,967,520 in revenue, with the lowest revenue forecast at $1,091,967,520 and the highest revenue forecast at $1,091,967,520.